| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.
|
Cancer Res
|
2009
|
7.98
|
|
2
|
How basal are triple-negative breast cancers?
|
Int J Cancer
|
2008
|
3.18
|
|
3
|
Integrated profiling of basal and luminal breast cancers.
|
Cancer Res
|
2007
|
2.86
|
|
4
|
Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.
|
Cancer Res
|
2006
|
2.52
|
|
5
|
Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.
|
Cancer Res
|
2005
|
2.26
|
|
6
|
Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters.
|
Oncogene
|
2004
|
2.09
|
|
7
|
A gene expression signature identifies two prognostic subgroups of basal breast cancer.
|
Breast Cancer Res Treat
|
2010
|
2.03
|
|
8
|
Comprehensive profiling of 8p11-12 amplification in breast cancer.
|
Mol Cancer Res
|
2005
|
1.96
|
|
9
|
CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction.
|
Proc Natl Acad Sci U S A
|
2011
|
1.91
|
|
10
|
Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis.
|
Breast Cancer Res Treat
|
2010
|
1.81
|
|
11
|
Prognosis and gene expression profiling of 20q13-amplified breast cancers.
|
Clin Cancer Res
|
2006
|
1.75
|
|
12
|
Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome.
|
Blood
|
2008
|
1.74
|
|
13
|
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.
|
Br J Haematol
|
2010
|
1.71
|
|
14
|
Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy.
|
Cancer Res
|
2004
|
1.61
|
|
15
|
Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.
|
BMC Cancer
|
2006
|
1.58
|
|
16
|
Retinoid signaling regulates breast cancer stem cell differentiation.
|
Cell Cycle
|
2009
|
1.56
|
|
17
|
Genome profiling of pancreatic adenocarcinoma.
|
Genes Chromosomes Cancer
|
2011
|
1.54
|
|
18
|
Genome profiling of ERBB2-amplified breast cancers.
|
BMC Cancer
|
2010
|
1.53
|
|
19
|
Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms.
|
Genes Chromosomes Cancer
|
2012
|
1.47
|
|
20
|
ZNF703 gene amplification at 8p12 specifies luminal B breast cancer.
|
EMBO Mol Med
|
2011
|
1.47
|
|
21
|
CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.
|
Breast Cancer Res
|
2009
|
1.41
|
|
22
|
Identification and validation of an ERBB2 gene expression signature in breast cancers.
|
Oncogene
|
2004
|
1.31
|
|
23
|
Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets.
|
Clin Cancer Res
|
2013
|
1.30
|
|
24
|
Nectin-4 is a new histological and serological tumor associated marker for breast cancer.
|
BMC Cancer
|
2007
|
1.30
|
|
25
|
Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer.
|
PLoS One
|
2011
|
1.27
|
|
26
|
Kinome expression profiling and prognosis of basal breast cancers.
|
Mol Cancer
|
2011
|
1.22
|
|
27
|
How different are luminal A and basal breast cancers?
|
Int J Cancer
|
2009
|
1.15
|
|
28
|
High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes.
|
PLoS One
|
2011
|
1.14
|
|
29
|
ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.
|
Cancer Res
|
2013
|
1.14
|
|
30
|
Gene expression profiling and prediction of clinical outcome in ovarian cancer.
|
Crit Rev Oncol Hematol
|
2009
|
1.13
|
|
31
|
Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.
|
Stem Cells
|
2012
|
1.13
|
|
32
|
The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression.
|
Clin Cancer Res
|
2013
|
1.10
|
|
33
|
Gene expression profiling and clinical outcome in breast cancer.
|
OMICS
|
2006
|
1.10
|
|
34
|
Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition.
|
Cancer Res
|
2011
|
1.09
|
|
35
|
Moesin expression is a marker of basal breast carcinomas.
|
Int J Cancer
|
2007
|
1.09
|
|
36
|
High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma.
|
Int J Cancer
|
2012
|
1.08
|
|
37
|
Gene expression profiling of inflammatory breast cancer.
|
Cancer
|
2010
|
1.07
|
|
38
|
Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling.
|
Oncogene
|
2004
|
1.07
|
|
39
|
Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model.
|
PLoS One
|
2010
|
1.05
|
|
40
|
Loss, mutation and deregulation of L3MBTL4 in breast cancers.
|
Mol Cancer
|
2010
|
1.04
|
|
41
|
High frequency of chromosome 14 deletion in early-onset colon cancer.
|
Dis Colon Rectum
|
2007
|
0.99
|
|
42
|
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization.
|
Mol Cancer
|
2014
|
0.96
|
|
43
|
A gene expression signature of primary resistance to imatinib in chronic myeloid leukemia.
|
Leuk Res
|
2009
|
0.95
|
|
44
|
8q24 Cancer risk allele associated with major metastatic risk in inflammatory breast cancer.
|
PLoS One
|
2012
|
0.94
|
|
45
|
Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations.
|
Blood
|
2010
|
0.93
|
|
46
|
Absence of ESR1 amplification in a series of breast cancers.
|
Int J Cancer
|
2008
|
0.92
|
|
47
|
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial.
|
Breast Cancer Res
|
2011
|
0.91
|
|
48
|
Gene expression profiling of solitary fibrous tumors.
|
PLoS One
|
2013
|
0.88
|
|
49
|
Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers.
|
Breast Cancer Res
|
2013
|
0.86
|
|
50
|
Peritumoural vascular invasion: a major determinant of triple-negative breast cancer outcome.
|
Eur J Cancer
|
2011
|
0.86
|
|
51
|
Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts.
|
Haematologica
|
2012
|
0.86
|
|
52
|
ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling study.
|
Acta Neuropathol Commun
|
2013
|
0.84
|
|
53
|
Gene expression profiling and its utility in prediction of local relapse after breast-conserving therapy in early breast cancer.
|
Cancer Genomics Proteomics
|
2011
|
0.84
|
|
54
|
BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer.
|
Genes Chromosomes Cancer
|
2010
|
0.83
|
|
55
|
Interactome-transcriptome integration for predicting distant metastasis in breast cancer.
|
Bioinformatics
|
2012
|
0.82
|
|
56
|
Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome.
|
Stem Cells
|
2014
|
0.82
|
|
57
|
Contrasted outcomes to gefitinib on tumoral IGF1R expression in head and neck cancer patients receiving postoperative chemoradiation (GORTEC trial 2004-02).
|
Clin Cancer Res
|
2012
|
0.81
|
|
58
|
Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers.
|
Anticancer Res
|
2007
|
0.81
|
|
59
|
Comprehensive genome characterization of solitary fibrous tumors using high-resolution array-based comparative genomic hybridization.
|
Genes Chromosomes Cancer
|
2012
|
0.79
|
|
60
|
Alterations of polycomb gene BMI1 in human myeloproliferative neoplasms.
|
Cell Cycle
|
2012
|
0.79
|
|
61
|
Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents.
|
Breast Cancer Res Treat
|
2011
|
0.79
|
|
62
|
The CINSARC signature: prognostic and predictive of response to chemotherapy?
|
Cell Cycle
|
2010
|
0.78
|
|
63
|
Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer.
|
Breast Cancer Res Treat
|
2010
|
0.77
|
|
64
|
Prognostic Value of Molecular Subtypes in Pancreatic Cancer.
|
Pancreas
|
2017
|
0.76
|
|
65
|
[Prognostic classification of breast cancer and gene expression profiling].
|
Med Sci (Paris)
|
2008
|
0.76
|
|
66
|
Difference in therapeutic response between basal and nonbasal triple-negative breast cancers.
|
Oncologist
|
2013
|
0.75
|
|
67
|
Djeen (Database for Joomla!'s Extensible Engine): a research information management system for flexible multi-technology project administration.
|
BMC Res Notes
|
2013
|
0.75
|
|
68
|
Detection of driver protein complexes in breast cancer metastasis by large-scale transcriptome-interactome integration.
|
Methods Mol Biol
|
2014
|
0.75
|